✦ LIBER ✦

The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development

✍ Scribed by Philip, Noah S.; Carpenter, Linda L.; Tyrka, Audrey R.; Price, Lawrence H.

Book ID: 115500645
Publisher: The Scientific World
Year: 2012
Tongue: English
Weight: 532 KB
Volume: 2012
Category: Article
ISSN: 2356-6140
DOI: 10.1100/2012/104105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nicotinic acetylcholine receptors as tar

Nicotinic acetylcholine receptors as targets for antidepressants

✍ Shytle, R D; Silver, A A; Lukas, R J; Newman, M B; Sheehan, D V; Sanberg, P R 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Desensitization of Nicotinic Acetylcholi

Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug Development

✍ Buccafusco, J. J.; Beach, J. W.; Terry, A. V. 📂 Article 📅 2008 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 441 KB

The GABAB receptor as a target for antid

The GABAB receptor as a target for antidepressant drug action

✍ Subroto Ghose; Michelle K Winter; Kenneth E McCarson; Carol A Tamminga; Salvator 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 936 KB

The alpha7 nicotinic acetylcholine recep

The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation

✍ W J de Jonge; L Ulloa 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 321 KB

Brain histamine receptors as targets for

Brain histamine receptors as targets for antidepressant drugs

✍ Kanof, Philip D.; Greengard, Paul 📂 Article 📅 1978 🏛 Nature Publishing Group 🌐 English ⚖ 588 KB

Neuronal nicotinic acetylcholine recepto

Neuronal nicotinic acetylcholine receptors as a target for the treatment of neuropathic pain

✍ Michael D. Meyer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

## Abstract Neuronal nicotinic acetylcholine receptor (nAChR) agonists have been demonstrated to exhibit antinociceptive, antihyperalgesic, and antiallodynic effects across a range of preclinical models of pain. Yet, to date, no drugs have been successfully developed and approved for the treatment